Insufficient scRNA-seq data for expression of EXTL1 at single-cell level.
Insufficient scRNA-seq data for expression of EXTL1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 96% | 2020.65 | 2526 / 2642 | 98% | 10.53 | 693 / 705 |
| skin | 58% | 321.52 | 1047 / 1809 | 95% | 60.94 | 447 / 472 |
| adrenal gland | 64% | 201.64 | 165 / 258 | 63% | 2.52 | 146 / 230 |
| ovary | 63% | 209.59 | 114 / 180 | 54% | 1.46 | 234 / 430 |
| pancreas | 53% | 205.18 | 173 / 328 | 49% | 1.10 | 87 / 178 |
| eye | 0% | 0 | 0 / 0 | 100% | 80.69 | 80 / 80 |
| spleen | 96% | 742.12 | 232 / 241 | 0% | 0 | 0 / 0 |
| breast | 29% | 154.41 | 131 / 459 | 62% | 4.90 | 694 / 1118 |
| uterus | 66% | 354.99 | 112 / 170 | 17% | 0.97 | 80 / 459 |
| muscle | 75% | 746.59 | 606 / 803 | 0% | 0 | 0 / 0 |
| heart | 66% | 290.39 | 564 / 861 | 0% | 0 | 0 / 0 |
| intestine | 36% | 104.09 | 349 / 966 | 4% | 0.08 | 22 / 527 |
| thymus | 9% | 18.23 | 57 / 653 | 27% | 0.52 | 162 / 605 |
| prostate | 16% | 53.64 | 38 / 245 | 6% | 0.20 | 28 / 502 |
| bladder | 10% | 20.24 | 2 / 21 | 8% | 0.19 | 42 / 504 |
| stomach | 9% | 23.67 | 33 / 359 | 4% | 0.08 | 12 / 286 |
| lung | 3% | 6.04 | 15 / 578 | 9% | 0.21 | 102 / 1155 |
| kidney | 6% | 28.56 | 5 / 89 | 5% | 0.12 | 49 / 901 |
| esophagus | 7% | 23.64 | 96 / 1445 | 3% | 0.06 | 5 / 183 |
| adipose | 5% | 21.72 | 57 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.09 | 2 / 45 |
| blood vessel | 4% | 13.61 | 56 / 1335 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 3% | 0.11 | 14 / 406 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001501 | Biological process | skeletal system development |
| GO_0015012 | Biological process | heparan sulfate proteoglycan biosynthetic process |
| GO_0006486 | Biological process | protein glycosylation |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0008375 | Molecular function | acetylglucosaminyltransferase activity |
| GO_0015020 | Molecular function | glucuronosyltransferase activity |
| GO_0050508 | Molecular function | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | EXTL1 |
| Protein name | Exostosin-like 1 (EC 2.4.1.224) (Exostosin-L) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostosis-like protein) |
| Synonyms | EXTL |
| Description | FUNCTION: Glycosyltransferase required for the biosynthesis of heparan-sulfate (HS) . Transfers N-acetyl-alpha-D-glucosamine to the nascent HS chain (GlcNAcT-II activity) . Appears to lack GlcNAcT I and GlcAT-II activities . . |
| Accessions | Q92935 ENST00000374280.4 |